Monographie - Infliximab - Stabilis 4.0

Ultimo aggiornamento :
19/11/2024

Immunosoppressore

Infliximab

Iniezione

Collirio

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Flixabi	Belgio, Germania, Gran Bretagna, Spagna
Flixceli	Perù
Inflectra	Belgio, Canada, Germania, Gran Bretagna, Islanda, Italia, Romania, Spagna, Svizzera
Infliximab	Chile
Remicade	Arabia Saudita, Argentina, Australia, Austria, Belgio, Canada, Chile, Colombia, Danimarca, Ecuador, Emirati Arabi Uniti, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Grecia, Iran, Irlanda, Islanda, Italia, Lussemburgo, Malaysia, Messico, Norvegia, nuova Zelanda, Paesi Bassi, Perù, Polonia, Portogallo, Romania, Spagna, Stati Uniti d’America, Svezia, Svizzera, Tunisia, Turchia, Venezuela
Remsima	Argentina, Belgio, Canada, Chile, Ecuador, Francia, Germania, Gran Bretagna, Islanda, Italia, Norvegia, Perù, Romania, Spagna, Svizzera, Turchia
Zessli	Belgio, Germania, Gran Bretagna

Bibliografia

Iniezione

Bibliografia : Infliximab

	tipo	pubblicazione
754	Laboratorio	Infliximab (Remicade®) – Summary of Product Characteristics Merck Sharp & Dohme 2019
2296	Laboratorio	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
3137	Rivista	Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS. Infliximab stability after reconstitution, dilution, and storage under refrigeration. Retina 2010 ; 30, 1: 81-84.
3317	poster	Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. Stabilité de l'infliximab en solutions diluées. APHIF Congress 2009
3333	Rivista	Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M. Stability of infliximab in polyvinyl chloride bags. Am J Health-Syst Pharm 2012 ; 69:1509-1512.
3825	Rivista	Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G. Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance. J Pharm Pract and Res 2015 ; 496: 421-431.
3924	Rivista	Vieillard V, Astier A, Sauzay C, Paul M. One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Ann Pharm Fr 2016 ; 75, 1 : 17-29.
4003	Rivista	Kim J, Chung J, Park S, Jung S, Kang D. Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). EJHP 2017 ; 25, 3: 157-164.
4049	Rivista	Tokhadze N, Chennell P, Le Basle Y, Sautou V. Stability of infliximab solutions in different temperature and dilution conditions. J Pharm Biomed Anal 2018 ; 150 : 386-395
4279	Rivista	Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Bio Drugs 2019 ; 33: 193–205.
4292	Rivista	Vimpolsek M, Gottar-Guillier M, Rossy E. Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. Drugs R D 2019 19: 127–140.

Mentions Légales